Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Predictive Oncology Q2 EPS $(0.68) Up From $(0.98) YoY, Sales $278.72K Down From $490.11K YoY

Author: Benzinga Newsdesk | August 14, 2024 02:43am

Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.68) per share. This is a 30.61 percent increase over losses of $(0.98) per share from the same period last year. The company reported $278.72 thousand in sales this quarter. This is a 43.13 percent decrease over sales of $490.11 thousand the same period last year.

Posted In: POAI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist